With in-person teaching in hospital and clinic settings suspended as the COVID-19 pandemic emerged, Weill Cornell Medical College swiftly designed innovative telehealth courses that enabled medical students to take part in remote patient care while also positioning them for post-pandemic careers with expanded digital healthcare options.
Adding antibiotics to usual care does not improve outcomes for people with the lung disease idiopathic pulmonary fibrosis (IPF), according to the findings from a multi-center, phase 3 clinical trial sponsored by Weill Cornell Medicine.
Women who receive COVID-19 mRNA vaccines produced by Pfizer-BioNTech or Moderna while in their third trimester of pregnancy generate a strong immune response and pass protective antibodies through umbilical cord blood to their babies.
Each year over 150,000 infants worldwide are infected with HIV in the womb, at birth, or through breastfeeding. Why transmission occurs in some cases but not others has long been a mystery, but now a team led by Weill Cornell Medicine and Duke University scientists has uncovered an important clue, with implications for how to eliminate infant HIV infections.
With vaccine availability growing in New York City and across the country, attention is increasingly turning to those who are eligible but hesitant about getting the shot
Medicines that contain radioactive isotopes—known as radiopharmaceuticals—are used to treat cancer and to help physicians diagnose a wide variety of conditions through imaging. But while radiopharmaceuticals are a standard and invaluable medical tool in the field of nuclear medicine, synthesizing them can be challenging.
Vinay Chadha is the finance director of a fitness company, and exercise has always been important to him. But when the pandemic hit New York City this past March, the 37-year-old found his activities drastically curtailed—first when he fell ill with COVID-19, then by the statewide shelter-in- place order.
Health Matters spoke with Dr. Simon, an assistant professor of medicine in the Division of Infectious Diseases at Weill Cornell Medicine, to understand the different kinds of masks and why it might make sense to start double masking.
Patients with acute myeloid leukemia that has gone into remission following initial chemotherapy remain in remission longer and have improved overall survival when they are given a pill form of the cancer drug azacitidine as a maintenance treatment.
The COVID-19 vaccine rollout is underway, bringing a sense of hope — as well as many questions about safety and who should get the vaccine. To help answer these questions, NewYork-Presbyterian experts address common concerns about the new Moderna and Pfizer-BioNTech COVID-19 vaccines and explain why they are safe.
The risk of dying seven years after coronary artery bypass surgery was significantly lower in men receiving multiple bypass grafts rather than single grafts, but there was no apparent difference in mortality between these methods in women.
Patient mistrust of the healthcare system, which has come under new focus during the COVID-19 pandemic, is partly the result of an increasingly consumer-oriented healthcare system, according to a new commentary by a Weill Cornell Medicine investigator.
Seeking to advance the scope of precision medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, and Illumina, Inc. are entering into a collaboration to sequence the complete human genomes of thousands of consenting patients.
The immunotherapy drug pembrolizumab, known by its brand name Keytruda, is a safe and effective option for patients with locally advanced and metastatic squamous cell esophageal cancer who have already received standard chemotherapy, according to a new study co-authored by a Weill Cornell Medicine and NewYork-Presbyterian investigator.
Researchers from Weill Cornell Medicine, Cornell University and San Jose State University have identified six free planning models for estimating hospital capacity requirements when COVID-19 cases surge.
When a patient is hospitalized with COVID-19, signs of damage to the right side of the heart may indicate a greater risk of death, according to a study from investigators at Weill Cornell Medicine and NewYork-Presbyterian.
